Impact factor (WEB OF SCIENCE - Clarivate)

2 year: 4.413 | 5 year: 5.197

Articles

Basic and associated causes of schistosomiasis-related mortality in Brazil: A population-based study and a 20-year time series of a disease still neglected

Wandklebson Silva da Paz1, 2, Erica dos Santos Reis1, 3, Iane Brito Leal3, Yanna Menezes Barbosa3, Karina Conceição GM de Araújo1, 3, 4, Amélia Ribeiro de Jesus3, 5, 6, Carlos Dornels Freire de Souza7, Allan Dantas dos Santos8, 9, Márcio Bezerra-Santos1, 3, 4, 6

1 Parasitic Biology Graduate Program, Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil
2 Tropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil
3 Health Sciences Graduate Program, Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil
4 Department of Morphology, Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil
5 Department of Medicine, Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil
6 Immunology and Molecular Biology Laboratory, University Hospital, Universidade Federal de Sergipe, Aracaju, Brazil
7 Department of Medicine, Universidade Federal de Alagoas, Arapiraca, Alagoas, Brazil
8 Department of Nursing, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil
9 Nursing Graduate Program, Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Abstract

Background

Schistosomiasis is a persistent public health problem in Brazil. Regardless advances in diagnosis and mass treatment, schistosomiasis has a severe impact on morbimortality in the country and remains a neglected tropical disease. Herein, we assessed the basic and associated causes of schistosomiasis-related deaths and the temporal and spatial patterns of mortality from the disease in Brazil between 1999 and 2018.

Methods

We conducted an ecological and time series study. The segmented log-linear regression model was applied to assess time trends, considering all deaths recorded in the category B65/ICD-10. Additionally, we elaborated maps of mortality rates from schistosomiasis in Brazil.

Results

A total of 4168 schistosomiasis-related deaths were recorded in Brazil in this period, as an associated cause. Time trend analysis revealed an increase in the average age of deaths from schistosomiasis (annual percentage change (APC) = 0.84), and stable trend in Brazil (APC = 0.31). Concerning schistosomiasis-related deaths, we observed disorders related to the digestive system, liver diseases, septicemias, and chronic diseases. Surprisingly, there were deaths caused by non-endemic Schistosoma species in Brazil. Also, municipalities from non-endemic areas in Brazil presented schistosomiasis-related deaths.

Conclusion

Altogether, our analyses demonstrated that schistosomiasis remains a significant cause of death in Brazil, and it is increasing in some areas, especially in the Northeast region. Additionally, women and the elderly showed a stable time trend of deaths. Thereby, it urgently requires improvements in the control programs strategies, in the sense of an effective reduction in cases and deaths from the disease in Brazil.

Print Friendly, PDF & Email

Schistosomiasis is the second most impacting parasitic disease in the world (behind only malaria), with about 240 million cases. It is considered a neglected tropical disease and affects mainly areas of greatest social vulnerability in sub-Saharan Africa, Asia, and Latin America [1]. Brazil is endemic only for the species Schistosoma mansoni, which causes intestinal schistosomiasis. The disease has two clinical phases: the acute phase eventually presents cercarial dermatitis and non-specific symptoms such as fever, nausea, and headache; in the chronic phase there may be abdominal pain, diarrhea, and blood in the stool [1]. Liver and spleen enlargement is observed in advanced cases and is frequently associated with portal hypertension, ascites, collateral circulation, and esophageal varices. The severe hepatosplenic form is responsible for most deaths in schistosomiasis [1,2]. To date, praziquantel is the recommended treatment against all clinical forms of the diseases. This drug is safe, effective, low-cost, and reduce the risk of developing the severe clinical forms and deaths from schistosomiasis [1].

In Brazil, by virtue of the activities of the Schistosomiasis Control Program (PCE), there has been a significant reduction in schistosomiasis severity indicators in recent decades [3]. Additionally, the improvements in health service strategies, as diagnosis and mass treatment in endemic areas, have dropped the number of cases and deaths and increased life expectancy for ill patients [3]. Regardless all these measures, schistosomiasis remains endemic in many states, mainly in the Northeast region [4,5]. PCE estimates point to 1.5 million individuals infected with S. mansoni in Brazil. More importantly, many of these cases occur in the elderly, and this considerably increases the risk of association with chronic non-infectious diseases as cardiovascular or digestive diseases, and neoplasms. Furthermore, prior studies conducted by our group showed an increase in the schistosomiasis mortality rate in age groups above 60 years [4,6]. Thereby, it suggests the chronicity of the disease, a higher risk of association with comorbidities, and death [3,7].

The World Health Organization (WHO) recommends that mortality statistics should be presented according to the basic cause of death, defined as the disease or injury that initiated the sequence of events that directly caused death [810]. Notwithstanding, especially for infectious and parasitic diseases, there is also a need for more comprehensive information related to death [8,9]. Herewith, it is necessary to consider all mortality causes recorded in the death certificates that include, in addition to the basic causes, the associated causes.

Notably, the occurrence of comorbidities increases the risk of clinical complications and deaths from schistosomiasis and this can be evaluated by identifying associated causes in the death certificate [9]. Considering this, assessing the basic and associated causes of death can improve to health systems, especially in mortality risk analysis. In that regard, temporal and spatial analysis techniques are one of the most efficient methods, since they allow to monitor the impacts of the disease over time and in space [9,11]. Several studies have used spatial and spatiotemporal analysis tools to comprehend the dynamics of schistosomiasis in Brazil [4,6,12]. Nevertheless, there are no studies investigating the associated causes of death from the disease at the national level. Herein, we hypothesize that the mortality rate from schistosomiasis may be higher among men, as they are usually more affected by the disease in endemic areas. Also, mortality from schistosomiasis is higher in the elderly, especially among those with some coexisting illnesses.

Considering that S. mansoni infection remains an important public health concern in Brazil and the lack of studies assessing comorbidities related to mortality from schistosomiasis, we conducted the first study to assess the basic and associated causes, and the temporal and spatial patterns of schistosomiasis-related deaths in Brazil between 1999 and 2018.METHODS

Type of study and period

We conducted an ecological, population-based, and time series study (from 1999 to 2018), using temporal and spatial analysis tools. We delimited this period considering that since 1999 Brazil started to use a new version of the Mortality Information System (SIM), for which a new death certificate was established [13]. After that, there were improvements in data recording, with more detailed filling in of the death certificate and inclusion of additional information, as associated causes of death [8].

Study area

Brazil is in South America and is the fifth largest country in the world, with approximately 211 million inhabitants [14]. The country is divided into 27 federative units and 5570 municipalities. In addition, the states are grouped into five regions: North, Northeast, Southeast, South, and Midwest, with distinct geographical, economic, and cultural characteristics. In physiographic aspects, Brazil has an extensive area of tropical forests, as the Amazon and Atlantic rainforest, and extensive water collections throughout the territory [14]. Regardless being classified as the 12th largest economy in the world (Gross Domestic Product – GDP/2020 = R$7.4 trillion; dropped 4.1% last year), Brazil has important socioeconomic disparities [14]. Furthermore, there is a lack of a sewerage system and safe-drinking water access in many municipalities, which maintains the schistosomiasis transmission cycle [6,15].

Data source

Data was obtained from the death certificate, available in the SIM of the Brazilian Ministry of Health. This statement is the standard SIM document and consists of a form filled out by medical professionals and contains demographic and clinical information, regarding the basic and associated causes of death [16]. SIM data are in public domain and can be obtained from the website of the Informatics Department of the Unified Health System (DATASUS). Additionally, population data were obtained from the Brazilian Institute of Geography and Statistics (IBGE), based on data from the national population census in 2000 and 2010, and official estimates for the inter-census years. The digital cartographic mesh, in shapefile format, was extracted from the Geographic Projection System, of the IBGE website (Geodesic Reference System, SIRGAS-2000).

Variables and measures

Herein, we assessed the following variables:

  1. Absolute number of schistosomiasis-related deaths (considering basic and associated causes) registered in the 5570 municipalities;
  2. Crude mortality rates for schistosomiasis-related deaths. Rates were calculated dividing the number of deaths from schistosomiasis by the population. The result was multiplied by 100 000 inhabitants in each municipality, state, and region. These rates were also calculated according to gender and age group;
  3. Average age at death for each year of the study;
  4. Proportion between the number of municipalities with death records and the total of municipalities for each year.

Data analysis

Evaluation of the epidemiological profile of schistosomiasis-related deaths in Brazil

Deaths from schistosomiasis are included in the subcategories from the category B65 (Schistosomiasis-Bilharziasis), from the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (International Classification of Disease/ICD-10) [17]. After selecting deaths from schistosomiasis as an associated cause, we performed the descriptive epidemiological characterization of these deaths. We carried out a bivariate statistical analysis of the factors associated with deaths from schistosomiasis. For variables with only two categories, they were compared to each other (ie, gender). For variables with more than two categories, each one was compared with the one with the lowest number of deaths (ie., age group). We also calculated the odds ratio (OR) and the 95% confidence intervals (95% CI) for all assessed variables. For these statistical analyses, we used the χ2 test, and the results were considered statistically significant when P-value <0.05 was obtained.

Description of diseases and disorders associated with mortality from schistosomiasis in Brazil

Subsequently, we conducted the decoding and description of the basic and associated causes, in which schistosomiasis was mentioned, from the death certificates:

  1. we include all associated causes mentioned in the death certificates, in which schistosomiasis was considered the basic cause of death;
  2. correspondingly, we considered all the basic causes of death, in which schistosomiasis was mentioned as an associated cause.

Usually in death certificates, they repeat the same basic cause among the associated causes of death [18]. Hereupon, to avoid repetition bias in the description of associated causes, mention that also repeated schistosomiasis as the basic cause was excluded. Concerning that, tables were created with data on the basic and associated causes of deaths from schistosomiasis. We organized them in a ranking of absolute and percentage frequencies.

Time trend analysis

Next, we assessed the time trends of the data using joinpoint regression models (segmented linear regression). This method allows to verify changes in the trend of a variable over time [19]. First, we used the Monte Carlo permutation test to identify the best segment of each model. We applied 9999 permutations and the best model was the one with the highest residue determination coefficient (R2). Afterwards, the annual percentage change (APC) and its respective confidence interval (95% CI) were calculated for each segmented period. Herein, positive and significant APC (P-value <0.05) indicates an increasing time trend. Alternatively, negative and significant APC indicates a decreasing trend, while APC that was not significantly different, indicates a stationary trend [19]. In addition, when a time trend had inflection points and more than one APC, we calculated the average annual percentage change (AAPC) for the entire period. The time trends were considered statistically significant when APC or AAPC had a P-value <0.05 and their 95% CI does not include a zero value.

Spatial distribution of data

Lastly, we elaborated choropleth maps of Brazil, divided by municipalities, representing the schistosomiasis-related deaths, and considering the basic or associated cause of death, available in subcategory B65/ICD-10. Additionally, data and maps were stratified according to the following categories: Schistosoma haematobium (B65.0); Schistosoma mansoni (B65.1); Schistosoma japonicum (B65.2); Cercarial dermatitis (B65.3); Other schistosomiases (B65.8); Schistosomiasis non-specified (B65.9).

Software

The study data were tabulated in Microsoft Excel (2019) spreadsheets. Statistical analysis was performed using the GraphPad Prism version 8.0.1. For time trend analysis, we used the Joinpoint Regression Program version 4.2.0. For spatial analysis and construction of choropleth maps, we used the QGis software version 3.4.RESULTS

We identified a total of 4168 deaths from schistosomiasis, as an associated cause, in Brazil between 1999 to 2018. Considering the epidemiological variables of the study, the highest OR for schistosomiasis-related deaths were observed in women, in the age groups of 40-59 and ≥60 years old, and in patients from the Northeast and Southeast regions (Table 1). Moreover, we compared the total number of deaths among the three states with the highest proportions of deaths from schistosomiasis and the other states of the country (Table S1 in the Online Supplementary Document) and interestingly, we observed that patients from these three states together showed about 4-fold higher chance of death from schistosomiasis in relation to all other states in Brazil.

Table 1.  Bivariate statistical analysis between epidemiological variables and deaths related to schistosomiasis as an associated cause in Brazil, between 1999 and 2018

n – number of samples, OR – odds ratio, CI – confidence interval, SP – São Paulo, PE – Pernambuco, AL – Alagoas

*We excluded missing and/or ignored data, or lacking information from the municipality of residence.

†Deaths related to schistosomiasis as an associated cause in Brazil.

Concerning the temporal patterns of schistosomiasis mortality as an associated cause, we observed a stable time trend in Brazil between 1999 and 2018 (Table 2). Likewise, we observed a stable time trend in all regions of the country. However, the Northeast region showed an increasing time trend in deaths from schistosomiasis between 1999 and 2016. Correspondingly, there was an increasing trend of deaths among women in the same period. On the other hand, there was stability in deaths among men. Despite the decreasing trend in most age groups, we observed stability in deaths among patients ≥60 years old. Conversely, we identified an increasing time trend in the average age at death from schistosomiasis.

Table 2.  Temporal trend analyses of schistosomiasis-related deaths as an associated cause, according to sociodemographic variables and places of residence in Brazil from 1999 to 2018

APC – annual percentage change, AAPC – average annual percentage change, CI – confidence interval

*P-value <0.05.

†Northeast region AAPC = -0.01; 95% CI = -3.73 to 3.86; P-value = 0.99.

‡Female AAPC = -0.5; 95% CI = -2.4 to 1.5; P-value = 0.66.

Interestingly, when we considered all the associated causes to deaths from schistosomiasis, we identify as the main causes those regarding to the digestive system, mainly disorders involving hepatic impairment (Table 3). The highest percentages were observed in unspecified diseases of the digestive system (K92 = 13.51%), unspecified liver diseases (K76 = 11.28%), shock (R57 = 8.90%), esophageal varices (I85 = 8.10%), liver fibrosis and cirrhosis (K74 = 7.85%), and liver failure (K72 = 7.79%). Similarly, when we consider the basic causes of death, in which schistosomiasis was included as an associated cause, we identified mainly disorders related to the digestive system (31.02%), especially liver diseases (Table 4). It was found that the main basic causes were concentrated in the chapters on diseases of the digestive system, mainly involving the liver, which together reached 31.02% of deaths from schistosomiasis as an associated cause. In addition, infectious diseases such as hepatitis were present in 6% of deaths as basic cause.

Table 3.  Identification and frequency (absolute and percentage) of associated causes with deaths from schistosomiasis in Brazil between 1999 and 2018

Table 4.  Identification and frequency (absolute and percentage) of the basic causes of death, in which schistosomiasis was mentioned as an associated cause in Brazil between 1999 and 2018

Table 5 shows the frequency of deaths according to the clinical forms of schistosomiasis and included in the category B65 of death certificates. We observed that the main clinical form of deaths was intestinal schistosomiasis, among the basic and associated cause. Surprisingly, although Brazil has no record of transmission of other Schistosoma species, we identified deaths from schistosomiasis caused by Schistosoma haematobium and Schistosoma japonicum. Unfortunately, there was no specification of the type of schistosomiasis, or the parasite, in 32.22% of the basic and in 42.97% of the associated causes.

Table 5.  Absolute frequency and percentage of deaths from schistosomiasis, according to the clinical presentation of the ICD-10 (category B65) in the death certificate, among the basic and associated causes in Brazil, from 1999 to 2018

Spatial analysis maps showed that deaths were concentrated in municipalities located on the country’s coastal strip, mostly in states from the Northeast and Southeast regions (Figure 1, Panel A and B). Surprisingly, although the North region is considered non-endemic for schistosomiasis, data on spatial distribution showed records of deaths in municipalities from that region.

Figure 1.  Spatial distribution maps of deaths from schistosomiasis in Brazil, according to the disease’s clinical presentation of the ICD-10. A) Basic causes of death. B) Associated causes of death.

Additionally, when assessing the distribution of deaths from basic causes, most municipalities had unspecified schistosomiasis as the main cause of death (n = 965 municipalities), followed by schistosomiasis caused by S. mansoni (n = 922; Figure 1, Panel A). Interestingly, there was record of death from urinary schistosomiasis (by S. haematobium) in 145 municipalities, and from S. japonicum infection in 22 municipalities. Likewise, when considering the associated causes, the main clinical form was unspecified schistosomiasis (n = 541; Figure 1, Panel B), followed by schistosomiasis by S. mansoni (n = 363). Furthermore, there were records of deaths from urinary schistosomiasis (n = 18) and from S. japonicum infection (n = 14).

DISCUSSION

Despite all the measures implemented by the PCE, as diagnosis and mass treatment of populations in endemic areas, schistosomiasis still has a high number of cases and deaths, and remains a serious public health concern in Brazil[6,11,20]. Herein, we conducted a pioneer, and population-based study, to assess the epidemiological profile and spatial and temporal patterns of deaths from schistosomiasis in Brazil, as basic and associated cause, in a period of 20 years. Importantly, our analyzes demonstrate stability of deaths from the disease in the country during the study period. Furthermore, we identified the occurrence of deaths in non-endemic municipalities and deaths caused by non-endemic Schistosoma species in Brazil. Taken together, our analyses allowed us to understand more reliably the dynamics of deaths from the disease in Brazil over time and in space.

Surprisingly, we observed higher schistosomiasis mortality rates among women. Usually, men are more exposed to S. mansoni infection, due to occupational activities (ie, fishing or farming), or leisure activities [6,21,22]. As a result, schistosomiasis death use to be higher in this group [4,6,23]. On the other hand, we observed a decreasing time trend in the mortality rate in men, and stability of deaths in women. We consider that most of cases among women occur in riverside communities from endemic areas. Despite the actions of the PCE, there was no control of the disease in these regions over time and, therefore, maintained the transmission and stability of deaths among women.

Time trend analyzes also showed stability in deaths from schistosomiasis in all regions of Brazil. However, the Northeast region showed an increasing trend from 1999 to 2016. Notably, Brazil is a country of continental dimensions and with significant physiographic and socioeconomic differences among regions. Thereby, these regional disparities and ecological variations reflect the number of cases and deaths from schistosomiasis throughout the country [5,7,24]. Hereupon, the Northeast region still presents precarious indicators of drinking water supply and sewerage system, and in accessing to specialized health services, mainly in inland cities [6,25]. In addition to promoting the maintenance of the parasite’s transmission cycle, these conditions cause delays in the diagnosis and timely treatment of ill patients. As a result, there is a higher risk for the occurrence of severe clinical forms, as the chronic hepatosplenic form, and death [12,26].

Remarkable, assessing comorbidities associated to schistosomiasis expands knowledge about clinical aspects and the epidemiological profile of the disease. Importantly, due to the increase in the number of cases in the elderly and the life expectancy among patients with schistosomiasis in recent decades, there was a greater likelihood of the coexistence of chronic diseases such as neoplasms, diabetes, obesity, and hypertensive diseases [26,27]. Correspondingly, we identified many disorders related to the digestive, circulatory, and respiratory systems, which may be indicative of the clinical complications of the chronic hepatosplenic phase of the disease [28,29].

Additionally, we observed a high number of infectious diseases as associated causes to schistosomiasis, mainly viral hepatitis, septicemia, and pneumonia. Prior studies have investigated the association between schistosomiasis and hepatitis caused by viruses B and C, especially in Egypt and Brazil [12,3032]. The authors emphasize that the occurrence of both infections can further aggravate the patient’s clinical condition, with a greater risk of liver fibrosis, portal hypertension, and the progression of hepatic fibrosis into cirrhosis and hepatocellular carcinoma, which considerably increases the risk of death [31,32].

In this study, the high number of deaths from schistosomiasis associated with hypertensive diseases and diabetes mellitus can be related to the increase in mortality in the elderly, where these coexisting diseases are more common [33]. Furthermore, the presence of renal and cardiovascular diseases can be even more severe in patients with the hepatosplenic chronic form of schistosomiasis [28,29]. Therefore, the high number of coexisting illnesses can be an indicator of a worse prognosis in elderly patients, and it assumes that there is a higher risk of death from schistosomiasis. Taken together, our findings reinforce the need to assess the occurrence of comorbidities in patients with schistosomiasis, especially in those with chronic forms, in order to initiate appropriate treatment and reduce the risk of clinical complications and death.

Unexpectedly, we identified death related to S. haematobium or S. japonicum infection, and other schistosomiasis, which may include the species S. intercalatum, S. mattheei, and S. mekongi. Notwithstanding, these Schistosoma species are commonly found in Africa and Asia [1]. Considering that Brazil does not have records of snails for the maintenance of the cycle of these species [5], it is unlikely that autochthonous transmission of other species of Schistosoma occurs in the country. Thereby, our findings may be due to the presence of Brazilians who traveled to endemic areas, became infected, and returned to Brazil where the death occurred. Alternatively, these data may be due to the death of immigrants or refugees from these endemic areas, which has increased exponentially in recent decades in Brazil [34,35].

The spatial distribution maps showed that municipalities with deaths from schistosomiasis are located mostly in the coastal strip of the Northeast and Southeast regions. In addition, these areas had high number of deaths caused by non-endemic Schistosoma species in Brazil[36]. Notably, states from the Northeast and Southeast regions have become the highest areas of flow of tourists and of immigrants in Brazil, mainly in the municipalities of the coastal areas. Importantly, the high number of visitors exposed to the S. mansoni infection in these areas may contribute to the disease spreading across the country and even to other continents.

Interestingly, most municipalities in Brazil had unspecified schistosomiasis as the leading cause of death, and not schistosomiasis caused by S. mansoni, as expected. These findings may indicate lacks in the accurate diagnosis of the disease’s etiology, as underreporting or misdiagnosis, or due to the inadequate filling out of death certificates by medical professionals. Nevertheless, the still significant number of deaths from schistosomiasis, historically endemic in the country, demonstrate failures in the disease control actions, as timely diagnosis and treatment to reduce the clinical complications of the disease [37].

Prior studies have reported a reduction in the number of S. mansoni infection in Brazil and suggesting the efficiency of PCE activities for controlling the disease [7,22]. Conversely, a study conducted by Cruz and colleagues [38] in the state of Sergipe, Northeastern Brazil, demonstrated failures in the conduct of the PCE in the state. Regardless the drop in the positivity rate from 2008 to 2017 (10.3% to 7.1%), there was also a significant reduction in the number of municipalities carrying out the PCE activities (APC = -3.96) and in the number of parasitological tests performed (APC = -9.58). The authors concluded that there was a decrease in the actions of the PCE in the municipalities of Sergipe. Furthermore, there was a tendency to increase cases with high parasitic load and, probably, severe cases. Thereby, we speculate that failures in the PCE activities may also be occurring in other states, which may explain the stable trend of deaths from the disease in Brazil.

Currently, the main effective actions to control schistosomiasis in endemic areas include diagnosis, mass treatment with the anthelminthic drug praziquantel, and Biomphalaria snails control [4,39,40]. Meanwhile, considering that schistosomiasis is a neglected tropical disease, we suggest that the goal of elimination schistosomiasis as a public health problem by 2030, as established by the WHO, will only be achieved if, in addition to those measures, there are improvements in the sewerage system and adequate water supply in social vulnerable areas in Brazil [1,6]. Despite this, in virtue of coronavirus disease 2019 (COVID-19), many diagnosis and mass treatment campaigns for schistosomiasis have been halted, with uncertain implications for the programs [40].

Regardless of these findings, our study has some limitations that deserve to be mentioned. Considering that we used secondary and public domain data, mortality rates can still be underreported, even after the notable progress made with improvements in the systems for recording deaths by SIM in Brazil. Additionally, the lack of PCE’s actions in some municipalities may limit the spatial data analysis. Finally, many chronic diseases affect mostly the elderly population, therefore, future studies should implement techniques to evaluate groups of cases while simultaneously adjusting the age range and/or other relevant covariates.

In the light of the above, our findings reinforce the importance of schistosomiasis as a serious and persistent public health concern in Brazil. Despite the implementation of the PCE control actions in the last decades, the disease showed a stable time trend of deaths in Brazil, among women, and in elderly. Furthermore, there was increasing trend in the Northeast region. Additionally, the occurrence of deaths caused by non-endemic Schistosoma species in Brazil reinforces the need for laboratory evaluation and clinical care in immigrants and refugees, and for Brazilians who have visited endemic areas for schistosomiasis in other countries. Considering this, improvements in the PCE actions, along with investments in public policies for education, public health, and the social inequalities in Brazil are essential to disrupt the biological cycle of the disease and, therefore, to reduce the schistosomiasis transmission and deaths, especially in low-income areas.

Additional material

Online Supplementary Document

Acknowledgments

We thank the Graduate Program in Parasitic Biology at the Federal University of Sergipe for the opportunity to carry out the research and the Graduate Program in Health Sciences for financial support for article submission.

Ethics approval and consent to participate: The data used are in the public domain without identification of the individuals. For this reason, the individual consent form did not need to be applied. Thus, the research did not have to go through the Ethics and Research Committee with Human Beings. However, the rules of the Helsinki Convention were followed.

[1] Funding: This research received financial support for article submission from the Graduate Program in Health Sciences at the Federal University of Sergipe.

[2] Authorship contributions: WSdPaz: Conceptualization, Data curation, Investigation, Methodology, Software, Writing – Review & Editing, Project administration, Writing – Original Draft. EdSR: Data curation, Investigation, Methodology, Writing – Review & Editing. IBL: Data curation, Investigation, Methodology. YMB: Data curation, Investigation, Methodology KCGMdA: Data curation, Software. ARdJ: Validation, Writing – Review & Editing. Carlos Dornels Freire de Souza: Validation, Writing – Review & Editing. ADdS: Conceptualization, Data curation, Investigation, Methodology, Writing – Review & Editing, Writing – Original Draft. MB-S: Conceptualization, Data curation, Investigation, Methodology, Software, Writing – Review & Editing, Supervision, Validation.

[3] Competing interests: The authors have completed the ICMJE Disclosure of Interest form (available upon request from the corresponding author), and declare that the possible conflict of interest is in relation to support for the present manuscript. The authors received financial assistance after accepting the article from the Graduate Program in Health Sciences at the Federal University of Sergipe to which 6 authors are affiliated. The support has been received for the author Karina Conceição Gomes Machado de Araújo. The payment of the fee to the journal was made by the author Márcio Bezerra-Santos.

references

[1] . Schistosomiasis and soiltransmitted helminthiases: numbers of people treated in 2017. Wkly Epidemiol Rec. 2018;93:681-92.

[2] Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de Vigilância em Saúde. 3a. Brasília: Coordenação-Geral de Desenvolvimento da Epidemiologia; 2019.

[3] TC Simões, R Sena, and KC Meira. The influence of the age-period-cohort effects on the temporal trend mortality from schistosomiasis in Brazil from 1980 to 2014. PLoS One. 2020;15:e0231874. DOI: 10.1371/journal.pone.0231874. [PMID:32324797]

[4] WS Paz, DS Gomes, RES Ramos, TM Cirilo, IGA Santos, and CJN Ribeiro. Spatiotemporal clusters of schistosomiasis mortality and association with social determinants of health in the Northeast region of Brazil (1980–2017). Acta Trop. 2020;212:105668. DOI: 10.1016/j.actatropica.2020.105668. [PMID:32805215]

[5] Katz N. Inquérito Nacional de Prevalência da Esquistossomose mansoni e Geo-helmintoses. Belo Horizonte, CPqRR: Fundação Oswaldo Cruz; 2018.

[6] W Silva da Paz, MS Duthie, AR Jesus, KCGM Araújo, AD dos Santos, and M Bezerra-Santos. Population-based, spatiotemporal modeling of social risk factors and mortality from schistosomiasis in Brazil between 1999 and 2018. Acta Trop. 2021;218:105897. DOI: 10.1016/j.actatropica.2021.105897. [PMID:33753030]

[7] FR Martins-Melo, MCC Pinheiro, AN Ramos, CH Alencar, FS de M Bezerra, and J Heukelbach. Trends in schistosomiasis-related mortality in Brazil, 2000–2011. Int J Parasitol. 2014;44:1055-62. DOI: 10.1016/j.ijpara.2014.07.009. [PMID:25161102]

[8] Ishitani LH, França E. Uso das causas múltiplas de morte em saúde pública. Inf Epidemiológico Do Sus. 2001;10.

[9] LH Ishitani, RA Teixeira, DMX Abreu, LMMM Paixão, and EB França. Qualidade da informação das estatísticas de mortalidade: códigos garbage declarados como causas de morte em Belo Horizonte, 2011-2013. Rev Bras Epidemiol. 2017;20:34-45. DOI: 10.1590/1980-5497201700050004. [PMID:28658371]

[10] BZ Oliveira, SLD Gotlieb, R Laurenti, and MHPM Jorge. Mortalidade feminina por hipertensão: análise por causas múltiplas. Rev Bras Epidemiol. 2009;12:556-65. DOI: 10.1590/S1415-790X2009000400006

[11] VS Barbosa, RM Loyo, RJPS Guimarães, and CS Barbosa. The Geographic Information System applied to study schistosomiasis in Pernambuco. Rev Saude Publica. 2017;51:107 DOI: 10.11606/S1518-8787.2017051000069. [PMID:29166439]

[12] MB Santos, AD Santos, PP Silva, AS Barreto, EO Santos, and AVC França. Spatial analysis of viral hepatitis and schistosomiasis coinfection in an endemic area in Northeastern Brazil. Rev Soc Bras Med Trop. 2017;50:383-7. DOI: 10.1590/0037-8682-0411-2016. [PMID:28700058]

[13] Brasil. Ministério da Saúde. Secretaria de Vigilância Epidemiológica. Manual de procedimentos do sistema de informações sobre mortalidade. 1a. Brasília: Fundação Nacional de Saúde; 2001.

[14] Instituto Brasileiro de Geografia e Estatítica (IBGE). Estimativas da População 2020. Diário da União 2020.

[15] Noya O, Katz N, Pointier JP, Theron A, de Noya BA. Schistosomiasis in America. Neglected Trop. Dis. – Lat. Am. Caribb., Viena: Springer; 2015.

[16] Brasil. Conselho Federal de Medicina. Centro Brasileiro de Classificação de Doenças. A Declaração de Óbito: documento importante e necessário. 3a. Brasilía: Ministério da Saúde; 2009.

[17] World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Genva: WHO; 2019.

[18] AH Santo and CE Pinheiro. Tabulador de causas múltiplas de morte. Rev Bras Epidemiol. 1999;2:90-7. DOI: 10.1590/S1415-790X1999000100009

[19] JLF Antunes and MRA Cardoso. Using time series analysis in epidemiological studies. Epidemiol Serv Saude. 2015;24:565-76. DOI: 10.5123/S1679-49742015000300024

[20] FR Martins-Melo, MCC Pinheiro, AN Ramos, CH Alencar, FSM Bezerra, and J Heukelbach. Spatiotemporal Patterns of Schistosomiasis-Related Deaths, Brazil, 2000 – 2011. Emerg Infect Dis. 2015;21:1820-3. DOI: 10.3201/eid2110.141438. [PMID:26401716]

[21] GL Nascimento and MRF Oliveira. Severe forms of schistosomiasis mansoni: epidemiologic and economic impact in Brazil, 2010. Trans R Soc Trop Med Hyg. 2014;108:29-36. DOI: 10.1093/trstmh/trt109. [PMID:24310377]

[22] FR Martins-Melo, AN Ramos, CH Alencar, and J Heukelbach. Mortality from neglected tropical diseases in Brazil, 2000–2011. Bull World Health Organ. 2016;94:103-10. DOI: 10.2471/BLT.15.152363. [PMID:26908960]

[23] AD Santos, MB Santos, PGR Santos, AS Barreto, and K Conceição Gomes Machado Araújo. Spatial analysis for the identification of risk áreas for schistosomiasis mansoni in the State of Sergipe, Brazil, 2005-2014. Rev Soc Bras Med Trop. 2016;49:608-15. DOI: 10.1590/0037-8682-0137-2016. [PMID:27812656]

[24] RS Amaral, PL Tauil, DD Lima, and D Engels. An analysis of the impact of the Schistosomiasis Control Programme in Brazil. Mem Inst Oswaldo Cruz. 2006;101:79-85. DOI: 10.1590/S0074-02762006000900012. [PMID:17308751]

[25] RR Silva, MB Santos, and AD Santos. Tavares D antos, Santos PL. Coronavirus disease and basic sanitation: too early to be worried? Rev Soc Bras Med Trop. 2020;53:e20200345. DOI: 10.1590/0037-8682-0345-2020. [PMID:32696810]

[26] E Sinkala, MC Kapulu, E Besa, K Zyambo, and NJ Chisoso. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Liver Int. 2016;36:145-50. DOI: 10.1111/liv.12891. [PMID:26058680]

[27] EF Drumond, CJ Machado, and PGO Salles. Análise de confiabilidade da causa básica e associadas de morte. Rev Da Fac Ciências Médicas Sorocaba. 2019;21:177-82. DOI: 10.23925/10.23925/1984-4840.2019v21i4a7

[28] DB Duarte, LA Vanderlei, RKA Bispo, ME Pinheiro, GB Silva, and AMC Martins. Renal Function in Hepatosplenic Schistosomiasis – An Assessment of Renal Tubular Disorders. PLoS One. 2014;9:e115197. DOI: 10.1371/journal.pone.0115197. [PMID:25531759]

[29] AO Mocumbi, C Goncalves, A Damasceno, and C Carrilho. Active schistosomiasis, severe hypereosinophilia and rapid progression of chronic endomyocardialendomyocardial fibrosis. Cardiovasc J Afr. 2016;27:e4-6. DOI: 10.5830/CVJA-2016-030. [PMID:27805245]

[30] A Hassanin, S Kamel, I Waked, and M Fort. Egypt’s ambitious strategy to eliminate hepatitis C virus: A case study. Glob Health Sci Pract. 2021;9:187-200. DOI: 10.9745/GHSP-D-20-00234. [PMID:33795369]

[31] DSM Van-Lume, MFPM Albuquerque, AI Souza, ALC Domingues, EPA Lopes, and CNL Morais. Association between Schistosomiasis mansoni and hepatitis C: systematic review. Rev Saude Publica. 2013;47:414-24. DOI: 10.1590/S0034-910.2013047004247. [PMID:24037369]

[32] A Farid, M Al-Sherbiny, A Osman, N Mohamed, A Saad, and MT Shata. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol. 2005;27:189-96. DOI: 10.1111/j.1365-3024.2005.00762.x. [PMID:15987342]

[33] World Health Organization. Cardiovascular diseases (CVDs). Geneva: WHO; 2017.

[34] KGAD Weerakoon, GN Gobert, P Cai, and DP McManus. Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev. 2015;28:939-67. DOI: 10.1128/CMR.00137-14. [PMID:26224883]

[35] World Health Organization. Crossing the billion: lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases and trachoma: preventive chemotherapy for neglected tropical diseases. Geneva: WHO; 2017.

[36] DG Colley, AL Bustinduy, WE Secor, and CH King. Human schistosomiasis. Lancet. 2014;383:2253-64. DOI: 10.1016/S0140-6736(13)61949-2. [PMID:24698483]

[37] CVV Rollemberg, MMBL Silva, KC Rollemberg, FR Amorim, NMN Lessa, and MDS Santos. Predicting frequency distribution and influence of sociodemographic and behavioral risk factors of Schistosoma mansoni infection and analysis of co-infection with intestinal parasites. Geospat Health. 2015;10:303 DOI: 10.4081/gh.2015.303. [PMID:26054512]

[38] JIN Cruz, G de O Salazar, and R La Corte. Retrocesso do Programa de Controle da Esquistossomose no estado de maior prevalência da doença no Brasil. Rev Panamazonica Saude. 2020;11:1-9.

[39] SH Sokolow, CL Wood, IJ Jones, SJ Swartz, M Lopez, and MH Hsieh. Global assessment of schistosomiasis control over the past century shows targeting the snail intermediate host works best. PLoS Negl Trop Dis. 2016;10:e0004794. DOI: 10.1371/journal.pntd.0004794. [PMID:27441556]

[40] K Kura, D Ayabina, J Toor, TD Hollingsworth, and RM Anderson. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies. Trans R Soc Trop Med Hyg. 2021;115:236-44. DOI: 10.1093/trstmh/traa202. [PMID:33515038]

Correspondence to:
Wandklebson Silva da Paz
Immunology and Molecular Biology Laboratory
Department of Pathology
University Hospital
Universidade Federal de Sergipe
Aracaju city, state of Sergipe
Brazil 49060108
wandklebson.paz@gmail.com